Cystic fibrosis in India: A systematic review

Dept. of Laboratory Medicine, PD Hinduja National Hospital and Medical Research Centre, Lalita Girdhar Building, Veer Savarkar Marg, Mumbai 400016, Maharashtra.
The Journal of the Association of Physicians of India 08/2012; 60(8):39-41.
Source: PubMed


CF, caused due to abnormal transport of chloride, sodium and bicarbonate ions across epithelial cell membranes, is a multi-organ disorder. More than 1000 mutations causing CF, have been identified in the CFTR gene, of which AF508 is the most severe, predominant mutation. However, data on CF in India is limited. Also, facilities for CF diagnosis are not available at all diagnostic centres across India.
AF508 mutation has been reported in 19-56% Indian patients. Also, the spectrum of mutations has been anticipated to be different, due to the identification of a wide range of novel and rare mutations. In addition to mutations, polymorphisms with clinical relevance and practical diagnostic value have also been identified. Clinical profile in Indian patients was also observed to be different.
Though, Cystic Fibrosis has always been considered to be a rare disease in India, we hope that the identification of the wide range of mutations, leads us to the recognition of a probable increased incidence of CF in Indian patients. And this would attract greater attention to the diagnosis of this disease, so that a clinically appropriate assay can be developed for their detection as a preliminary test for CF diagnosis. The results observed during the study can be a step forward in planning a molecular screening and providing appropriate genetic counseling programs, which are lacking in our country at the moment.

Download full-text


Available from: Pradnya Dhairyawan, Mar 13, 2014
    • "There are only few studies that describe genotypes of Indian children with CF. The frequency of ΔF508 mutation in Indian children with CF has been reported between 19 to 56% [46]. Also in other Asian countries, the reported proportion of children with ΔF508 is less than that seen in Caucasian population [47]. "

    No preview · Article · Dec 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: As a student I recall being told that half of what we would learn in medical school would be proven to be wrong. The challenges were to identify the incorrect half and, often more challenging, be willing to give up our entrenched ideas. Myths have been defined as traditional concepts or practice with no basis in fact. A misunderstanding is a mistaken approach or incomplete knowledge that can be resolved with better evidence, while firmly established misunderstandings can become dogma; a point of view put forth as authoritative without basis in fact. In this paper, I explore a number of myths, mistakes, and dogma related to cystic fibrosis disease and care. Many of these are myths that have long been vanquished and even forgotten, while others are controversial. In the future, many things taken as either fact or “clinical experience” today will be proven wrong. Let us examine these myths with an open mind and willingness to change our beliefs when justified.
    No preview · Article · Jan 2013 · Paediatric Respiratory Reviews
  • Source

    Full-text · Article · Mar 2014 · Indian pediatrics
Show more